Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 17, Number 11—November 2011

CME ACTIVITY - Research

Global Distribution and Epidemiologic Associations of Escherichia coli Clonal Group A, 1998–2007

James R. JohnsonComments to Author , Megan E. Menard, Tsai-Ling Lauderdale, Chris Kosmidis, David Gordon, Peter Collignon, Joel N. Maslow, Arjana Tambić Andrašević, and Michael A. Kuskowski
Author affiliations: Veterans Affairs Medical Center, Minneapolis, Minnesota, USA (J.R. Johnson, M.E. Menard, M.A. Kuskowski); University of Minnesota, Minneapolis (J.R. Johnson, M.A. Kuskowski); National Health Research Institutes, Zhunan, Taiwan (T.-L. Lauderdale); University of Athens Medical School, Athens, Greece (C. Kosmidis); Australian National University, Canberra, Australian Capital Territory, Australia (D. Gordon, P. Collignon); Canberra Hospital, Canberra (P. Collignon); Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA (J.N. Maslow); University of Pennsylvania, Philadelphia (J.N. Maslow); University Hospital for Infectious Diseases, Zagreb, Croatia (A. Tambić Andrašević)

Main Article

Table 1

Origin and epidemiologic background of 2,210 extraintestinal Escherichia coli isolates from 32 globally distributed centers and susceptibility to trimethoprim/sulfamethoxazole, 1998–2007*

Continent, location†

Year(s) of isolation

Total no. isolates

S, %

Source, no. isolates

No. CGA isolates/total no. (%)

Specimen type

Setting

Child‡

Urine

Nonurine

In

Out

R

S

Africa

    Ile-Ife, Nigeria

2004

41

NK

41

0

22

19

4

3/36 (8)

0/5 (0)

    Lusaka, Zambia

2001

51

59

4

37

NK

NK

0

0/31 (0)

0/20 (0)

Asia

    Chandigarh, India

2006

50

60

37

13

34

16

9

0/36 (0)

0/14 (0)

    Kitakyushu, Japan

2001–2005

56

80

37

19

36

20

7

1/29 (3)

0/27 (0)

    Singapore

2002

50

60

43

7

NK

NK

0

1/25 (4)

0/25 (0)

    Taiwan

1998–2004

320

46

256

64

66

254

73

8/161 (5)

8/159 (5)

Australia/New Zealand

    Canberra, Australia

1998–2001

121

80

50

71

0

121

5

10/60 (17)

3/61 (5)

    Palmerston North, New     Zealand

2006

51

78

36

15

18

33

3

1/24 (4)

0/27 (0)

Europe

    Zagreb, Croatia

2001–2002

91

81

44

47

58

33

0

8/46 (17)

1/45 (2)

    Athens, Greece

2003–2005

149

66

96

53

92

57

3

15/75 (20)

1/74 (1)

    Varese, Italy

2006

51

75

35

16

31

20

3

0/26 (0)

0/25 (0)

    Santander, Spain

2003

53

70

35

18

19

34

9

0/26 (0)

2/27 (7)

    Bellinzona, Switzerland

2006

54

75

36

18

34

20

2

3/27 (11)

0/27 (0)

North America

    Calgary, Alberta, Canada

2001

54

78

36

18

34

20

10

6/27 (22)

1/27 (4)

    United States

        Denver, CO

2001

100

78

50

50

50

50

0

17/50 (34)

3/50 (6)

        West Haven, CT

2006

34

76

24

10

17

17

0

0/16 (0)

0/18 (0)

        Chicago, Il

2001

60

74

40

20

37

23

0

0/30 (0)

0/30 (0)

        Lexington, KY

2001

60

80

40

20

7

53

5

3/30 (10)

1/30 (3)

        Petoskey, MI

2001

45

89

NK.

NK

NK

NK

0

5/21 (24)

0/24 (0)

        Duluth, MN

2001

50

90

39

11

8

42

0

4/26 (15)

0/24 (0)

        Minneapolis, MN†

2001

66

87

56

10

15

51

0

1/26 (4)

1/40 (3)

        Minneapolis, MN†

2001

46

90

38

8

21

25

0

0/18 (0)

0/28 (0)

        Northfield, MN

2001

24

95

24

0

0

24

0

1/12 (8)

0/12 (0)

        St. Louis Park, MN

2001

64

83

64

0

0

64

7

9/32 (28)

3/32 (9)

        Fargo, ND

2001

54

90

49

5

5

49

11

1/27 (4)

1/27 (4)

        Philadelphia, PA

2006

94

78

87

7

13

81

0

2/22 (9)

0/72 (0)

        Houston, TX

2001

60

65

40

20

35

25

9

1/30 (3)

1/30 (3)

        Salt Lake City, UT

2001

47

85

31

16

24

23

4

1/21 (5)

1/26 (4)

South/Central America

    Concepción, Chile

2006

51

57

36

15

33

18

NK

5/24 (21)

1/27 (4)

    Cali, Columbia

2005–2006

51

52

36

15

27

24

16

3/24 (13)

1/27 (4)

    Panama City, Panama

2007

54

36

36

18

19

35

52

1/27 (4)

1/27 (4)

    Lima, Peru

2002–2006

58

82

39

19

30

28

18

4/58 (7)

Not done

*S, susceptible to trimethoprim/sulfamethoxazole; in, inpatient; out, outpatient; CGA, clonal group A; R, resistant to trimethoprim/sulfamethoxazole; NK, not known.
†A list of the 32 centers is provided in the Technical Appendix. Note that 2 centers were located in Minneapolis.
‡<18 y of age.

*S, susceptible to trimethoprim/sulfamethoxazole; in, inpatient; out, outpatient; CGA, clonal group A; R, resistant to trimethoprim/sulfamethoxazole; NK, not known.
†A list of the 32 centers is provided in the Technical Appendix. Note that 2 centers were located in Minneapolis.
‡<18 y of age.

*S, susceptible to trimethoprim/sulfamethoxazole; in, inpatient; out, outpatient; CGA, clonal group A; R, resistant to trimethoprim/sulfamethoxazole; NK, not known.
†A list of the 32 centers is provided in the Technical Appendix. Note that 2 centers were located in Minneapolis.
‡<18 y of age.

Main Article

1Investigators who contributed data are listed at the end of this article.

TOP